MediPines Corporation
MediPines is a pioneer and market leader in non-invasive pulmonary gas exchange technology. The company’s mission is to advance respiratory medicine by providing physiology-based cardiorespiratory devices that enhance clinical effectiveness and achieve superior patient outcomes. The MediPines AGM100 is an industry award winning, FDA-cleared, advanced pulmonary gas exchange technology that exclusively provides Oxygen Deficit, a surrogate for the alveolar to arterial oxygen difference (AaDO2), as well as blood oxygen level (gPaO2), lung carbon dioxide level (PETCO2), and other sensitive measurements of pulmonary gas exchange, relevant for patients with respiratory and cardiac complications. AGM100 is used by medical providers and clinicians to raise diagnostic accuracy, improve treatment decisions, and accelerate healthcare decision making. MediPines is located in Orange County, California. The company is a FDA registered, California medical device manufacturing licensed (CDPH). All products are manufactured in a MDSAP/ISO13485 certified facility, the globally harmonized quality standard for medical devices.
Domain
medipines.com
Country
United StatesIndustry
Health CareEmployees
11-50
Last Funding
$3.1M
Founded
2013
Tech Stack (31 technologies)
Frequently Asked Questions
What technologies does MediPines Corporation use?+
MediPines Corporation uses 31 technologies including Bootstrap, Google Analytics, Google Tag Manager.
What industry is MediPines Corporation in?+
MediPines Corporation operates in the Health Care industry.
Where is MediPines Corporation based?+
MediPines Corporation is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: July 2026